Loading…
Kidney Care Access Protection Act
Legislative Progress
Introduced
November 20, 2025
Latest Action
November 20, 2025
Primary Sponsor
Carol D. MillerRepublican(WV)
Momentum (last 30 days)
4
score
0 actions · 2 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Medicare/Medicaid
S. 2730, H.R. 6214 The Kidney Care Access Protection Act; ESRD PPS and QIP rulemaking; CMMI Kidney Care Choices model
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
S. 2730, H.R. 6214 The Kidney Care Access Protection Act; ESRD PPS and QIP rulemaking; CMMI Kidney Care Choices model
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
Legislation and Regulation relating to Medicare policies and kidney care Living Donor Protection Act - H.R. 4583 and S. 1552 Amend the Family and Medical Leave Act - H.R. 4582 Kidney Care Access Protection Act - H.R. 6214 and S. 2730 Restore Protections for Dialysis Patients Act - H.R. 2199 and S. 1173
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $200,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
| Democratic |
| LA |
| Donald G. Davis | Democratic | NC |
| Gregory F. Murphy | Republican | NC |
| Jimmy Panetta | Democratic | CA |
| Joe Wilson | Republican | SC |
| Michael A. Rulli | Republican | OH |
| Mike Flood | Republican | NE |
| Mike Kelly | Republican | PA |
| Neal P. Dunn | Republican | FL |
| Nicholas A. Langworthy | Republican | NY |
| Shri Thanedar | Democratic | MI |
| Steve Cohen | Democratic | TN |
| Terri A. Sewell | Democratic | AL |
| Troy A. Carter | Democratic | LA |
| Yvette D. Clarke | Democratic | NY |
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
Dialysis reimbursement issues and issues related to the Medicare Secondary Payer program. H.R. 6214, Kidney Care Access Protection Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation, including S. 1552/H.R. 4582/3 - The Living Donor Protection Act; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Support increased oversight of Organ Procurement Organizations; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Support H.R. 2199/S. 1173 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; and Support S. 2730/H.R. 6214 - The Kidney Care Access Protection Act which would ensure appropriate reimbursement for quality care and improve patient access to innovative drugs, treatments, and technologies. Encourage Members of Congress to join the Congressional Kidney Caucus
Client expense: $200,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2026 · third_quarter · Medicare/Medicaid
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · third_quarter · Health Issues
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · third_quarter · Health Issues
Access to Genetic Counselor Services Act: H.R. 6280, S. 3607 Living Donor Protection Act: H.R. 4582, H.R 4583, S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 CMS-1846-P: Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program Medicaid Program; Community Engagement Requirement for Certain Individuals (CMS- 2454-IFC); Interim Final Rule with Comment Period
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Medicare/Medicaid
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) Model
Client expense: $1,120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Health Issues
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) Model
Client expense: $1,120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Health Issues
Issues related to End Stage Renal Disease, Acute Kidney Injury, Dialysis, and ESRD Treatment Choice Model. Telehealth. H.R. 6214/S. 2730 - Kidney Care Access Protection Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act. H.R. 8875 - Improving Home Dialysis Act of 2026.
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · third_quarter · Health Issues
Education about how to improve the quality of kidney care treatment, expand innovation, and other insurance/payment policies. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
Education about how to improve the quality of kidney care treatment and expand innovation. Modernize Medicares payment system for end-stage renal disease (ESRD). Medicare coverage and reimbursement related to dialysis. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750). Improving Home Dialysis Act of 2026 (H.R.8875).
Client expense: Not reported · Firm income: $110,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medicare/Medicaid
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act H.R. 6214/S. 2730 - The Kidney Care Access Protection Act H.R. 8319 - KIDNEY Remote Monitoring Act H.R. 4582 H.R. 4583/ S.1552 - Living Donor Protection Act
Client expense: $1,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Medicare/Medicaid
Issues related to Medicare policies impacting ESRD; Restore Protections for Dialysis Patients Act - H.R.2199/S.1173; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; Kidney Care Access Protection Act - H.R. 6214/S.2730
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2026 · third_quarter · Health Issues
Living Donor Protection Act (H.R. 4583 / S. 1552); FY 2027 appropriations funding for nursing workforce development programs and National Institute of Nursing Research; FY 2027 funding kidney disease research at NIDDK at NIH; Funding for AHRQ at HHS in FY 2027; Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2531 / S. 1232); Restore Protections for Dialysis Patients Act (H.R. 2199 / S. 1173); Organ Donation Referral Improvement Act (H.R. 330); The Improving Care & Access to Nurses Act (H.R. 1316 / S. 575); Providing Real-world Education and Clinical Experience by Precepting Tomorrow's Nurses Act (H.R. 392 / S. 131); Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R.929 / S.266); Living Donor FMLA Protection Act (H.R. 4582); Improving Access to Home Dialysis Act; Future Advancement of Academic Nursing Act (H.R. 6607 / S. 3435); Title VIII Reauthorization Act (H.R. 3593 / S. 1874); Kidney Care Protection Act (H.R. 6214 / S. 2730); Nursing is a Professional Degree Act (H.R. 8691 / S. 4568); Share Act (H.R. 2332); Promoting Access to Diabetic Shoes Act (H.R. 1616).
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
S. 2730, H.R. 6214 The Kidney Care Access Protection Act; ESRD PPS and QIP rulemaking; CMMI Kidney Care Choices model
Client expense: Not reported · Firm income: $23,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 6214, Kidney Care Access Protection Act S. 2730, Kidney Care Access Protection Act Implementation of P.L. 118-14, Continuing Appropriations Act, 2024 and Other Extensions Act, including provisions related to Title III, Health and Human Services. Implications of Supreme Court Decision on Marietta v. DaVita on Medicare Secondary Payer (MSP) statute and commercial group health insurance. FY 2026 Appropriations for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Implementation of P.L. 118-158, the American Relief Act of 2025, including provisions relating to health care.
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation, including S. 1552/H.R. 4582/3 - The Living Donor Protection Act; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Support increased oversight of Organ Procurement Organizations; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Support H.R. 2199/S. 1173 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; and Support S. 2730/H.R. 6214 - The Kidney Care Access Protection Act which would ensure appropriate reimbursement for quality care and improve patient access to innovative drugs, treatments, and technologies. Encourage Members of Congress to join the Congressional Kidney Caucus
Client expense: $500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2026 · second_quarter · Health Issues
Access to Genetic Counselor Services Act: H.R. 6280, S. 3607 Living Donor Protection Act: H.R. 4582, H.R 4583, S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Request for Information: Opportunities, Challenges, and Emerging Areas in Statistical Data, Analysis, and Research
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) Model
Client expense: $980,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Medicare/Medicaid
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 8376, Concurrent Care for Comfort Act H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program H.R. 8875, Improving Home Dialysis Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) Model
Client expense: $980,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · second_quarter · Health Issues
H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · second_quarter · Medicare/Medicaid
Issues related to Medicare policies impacting ESRD; Restore Protections for Dialysis Patients Act - H.R.2199/S.1173; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis; Kidney Care Access Protection Act - H.R. 6214/S.2730
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act U.S. Tariffs H.R. 6214/S. 2730 - The Kidney Care Access Protection Act H.R. 4582 H.R. 4583/ S.1552 - Living Donor Protection Act
Client expense: $1,190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · second_quarter · Health Issues
Issues related to End Stage Renal Disease, Acute Kidney Injury, Dialysis, and ESRD Treatment Choice Model. Telehealth. H.R. 6214/S. 2730 - Kidney Care Access Protection Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2026 · second_quarter · Medicare/Medicaid
Legislation and Regulation relating to Medicare policies and kidney care Living Donor Protection Act - H.R. 4583 and S. 1552 Amend the Family and Medical Leave Act - H.R. 4582 Kidney Care Access Protection Act - H.R. 6214 and S. 2730 Restore Protections for Dialysis Patients Act - H.R. 2199 and S. 1173
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Education about how to improve the quality of kidney care treatment, expand innovation, and other insurance/payment policies. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).
Client expense: Not reported · Firm income: $70,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Education about how to improve the quality of kidney care treatment and expand innovation. Modernize Medicares payment system for end-stage renal disease (ESRD). Medicare coverage and reimbursement related to dialysis. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750). Improving Home Dialysis Act of 2026 (H.R.8875).
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Living Donor Protection Act (H.R. 4583 / S. 1552); FY 2027 appropriations funding for nursing workforce development programs and National Institute of Nursing Research; FY 2027 funding kidney disease research at NIDDK at NIH; Funding for AHRQ at HHS in FY 2026; Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2531 / S. 1232); Restore Protections for Dialysis Patients Act (H.R. 2199 / S. 1173); Organ Donation Referral Improvement Act (H.R. 330); The Improving Care & Access to Nurses Act (H.R. 1316 / S. 575); Providing Real-world Education and Clinical Experience by Precepting Tomorrow's Nurses Act (H.R. 392 / S. 131); Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R.929 / S.266); Living Donor FMLA Protection Act (H.R. 4582); Improving Access to Home Dialysis Act; Future Advancement of Academic Nursing Act (H.R. 6607 / S. 3435); Title VIII Reauthorization Act (H.R. 3593 / S. 1874); Kidney Care Protection Act (H.R. 6214 / S. 2730); Nursing is a Professional Degree Act (H.R. 8691 / S. 4568).
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Dialysis reimbursement issues and issues related to the Medicare Secondary Payer program. H.R. 6214, Kidney Care Access Protection Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Medicare/Medicaid
Education about how to improve the quality of kidney care treatment and expand innovation. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).
Client expense: Not reported · Firm income: Not reported
2026 · second_quarter · Health Issues
Education about how to improve the quality of kidney care treatment and expand innovation. Kidney Care Access Protection Act of 2025 (H.R.6214/S.2730). Restore Protections for Dialysis Patients Act (H.R.8594/S.4750).
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Medicare/Medicaid
S. 2730, H.R. 6214 The Kidney Care Access Protection Act; ESRD PPS and QIP rulemaking; CMMI Kidney Care Choices model
Client expense: Not reported · Firm income: $23,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Medicare ESRD payment and quality programs rulemaking, Kidney Care Access Protection Act (S. 2730, H.R. 6214), the RESTORE Act (S. 1173, H.R. 2199), CKCC CMMI Model
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Medicare/Medicaid
Medicare ESRD payment and quality programs rulemaking, Kidney Care Access Protection Act (S. 2730, H.R. 6214), the RESTORE Act (S. 1173, H.R. 2199), CKCC CMMI Model
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Health Issues
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act H.R. 6214, Kidney Care Access Protection Act S. 2730, Kidney Care Access Protection Act Implementation of P.L. 118-14, Continuing Appropriations Act, 2024 and Other Extensions Act, including provisions related to Title III, Health and Human Services. Implications of Supreme Court Decision on Marietta v. DaVita on Medicare Secondary Payer (MSP) statute and commercial group health insurance. FY 2026 Appropriations for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Implementation of P.L. 118-158, the American Relief Act of 2025, including provisions relating to health care.
Client expense: $480,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
Issues related to the 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-105-F), specifically the inclusion of oral-only drugs in the ESRD PPS Bundled Payment. H.R.6214 - Kidney Care Access Protection Act Issues related to Most Favored Nation Drug Pricing Reform
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Medicare/Medicaid
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Health Issues
H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options
Client expense: $1,200,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Medicare/Medicaid
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act Working Families Tax Cut - Medicaid Provisions U.S. Tariffs The Budget Reconciliation bill - the "One Big, Beautiful Bill" Act. The VA/MILCON Appropriations Subcommittee bill. H.R. 6214/S. 2730- The Kidney Care Access Protection Act Kidney Care Choices Model and Skin Substitutes
Client expense: $1,760,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE